Integrated Filing — IndAS

General information about company
Scrip Code	500412
NSE Symbol	TIRUMALCHM
MSEI Symbol	NOTLISTED
ISIN	INE338A01024
Name of company	Thirumalai Chemicals Limited
Type of company	Main Board
Class of security	Equity
Date of start of financial year	01-Apr-2024
Date of end of financial year	31-Mar-2025
Date of board meeting when results were approved	16-May-2025
Date on which prior intimation of the meeting for considering financial results was informed to the exchange	08-May-2025
Description of presentation currency	INR (in Actuals)
Reporting Type	Quarterly
Reporting Quarter	Fourth quarter
Nature of report standalone or consolidated	Standalone
Whether results are audited or unaudited for the quarter ended	Audited
Whether results are audited or unaudited for the Year to date for current period ended/year ended	Audited
Segment Reporting	Single segment
Description of single segment	Chemical products and its intermediaries
Start date and time of board meeting	16-May-2025   10:30:00
End date and time of board meeting	16-May-2025   14:05:00
Whether cash flow statement is applicable on company	Yes
Type of cash flow statement	Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification	Declaration of unmodified opinion
Whether the company has any related party?	Yes
Whether the company has entered into any Related Party transaction during the selected half year for which it wants to submit disclosure?	Yes
(I) We declare that the acceptance of fixed deposits by the bans/Non-Banking Finance Company are at the terms uniformly applicable/offered to all shareholders/public	NA
(II) We declare that the scheduled commercial bank, as per RBI circular RBI/DBR/2015-16/19 dated March 03, 2016, has allowed additional interest of one per cent per annum, over and above the rate of interest mentioned in the schedule of interest rates on savings or a term deposits of banks staff and their exclusive associations as well as on deposits of Chairman, Chairman & Managing Director, Executive Director or such other Executives appointed for a fixed tenure.	NA
Whether the company is a high value debt listed entity according to regulation 15 (1A)?	No
(a) If answer to above question is Yes, whether complying with proviso to regulation 23 (9), i.e., submitting RPT disclosures on the day of results publication?
(b) If answer to above question is No, please explain the reason for not complying.
Whether the updated Related Party Transactions (RPT) Policy (in compliance with Reg. 23 of SEBI LODR) has been uploaded on the website of the Company?	Yes
Latest Date on which RPT policy is updated	2022-10-26
Indicate Company website link for updated RPT policy of the Company	https://thirumalaichemicals.com/compliance-policies/
Whether statement on deviation or variation for proceeds of public issue, rights issue, preferential issue, qualified institutions placement etc. is applicable to the company for the current quarter?	No
No. of times funds raised during the quarter
Whether the disclosure for the Default on Loans and Debt Securities is applicable to the entity?	No
Company has not made any defaults on loans.

Financial Results Ind-AS
Particulars		3 months/ 6 months ended (dd-mm-yyyy)	Year to date figures for current period ended (dd-mm-yyyy)
A	Date of start of reporting period	01-Jan-2025	01-Apr-2024
B	Date of end of reporting period	31-Mar-2025	31-Mar-2025
C	Whether results are audited or unaudited	Audited	Audited
D	Nature of report standalone or consolidated	Standalone	Standalone
Part I	Blue color marked fields are non-mandatory. For Consolidated Results, if the company has no figures for 3 months / 6 months ended, in such case zero shall be inserted in the said column.
1	Income
	Revenue from operations	5782100000	21520700000
	Other income	164600000	312000000
	Total income	5946700000	21832700000
2	Expenses
(a)	Cost of materials consumed	4177500000	16696600000
(b)	Purchases of stock-in-trade	429700000	466000000
(c)	Changes in inventories of finished goods, work-in-progress and stock-in-trade	-41500000	34900000
(d)	Employee benefit expense	131000000	588100000
(e)	Finance costs	156200000	444800000
(f)	Depreciation, depletion and amortisation expense	83100000	339000000
(f)	Other Expenses
1	Other Expenses	560500000	2218200000
	Total other expenses	560500000	2218200000
	Total expenses	5496500000	20787600000
3	Total profit before exceptional items and tax	450200000	1045100000
4	Exceptional items	0	0
5	Total profit before tax	450200000	1045100000
6	Tax expense
7	Current tax	67000000	219500000
8	Deferred tax	8100000	3500000
9	Total tax expenses	75100000	223000000
10	Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement	0	0
11	Net Profit Loss for the period from continuing operations	375100000	822100000
12	Profit (loss) from discontinued operations before tax	0	0
13	Tax expense of discontinued operations	0	0
14	Net profit (loss) from discontinued operation after tax	0	0
15	Share of profit (loss) of associates and joint ventures accounted for using equity method	0	0
16	Total profit (loss) for period	375100000	822100000
17	Other comprehensive income net of taxes	-215500000	507400000
18	Total Comprehensive Income for the period	159600000	1329500000
19	Total profit or loss, attributable to
	Profit or loss, attributable to owners of parent
	Total profit or loss, attributable to non-controlling interests
20	Total Comprehensive income for the period attributable to
	Comprehensive income for the period attributable to owners of parent
	Total comprehensive income for the period attributable to owners of parent non-controlling interests
21	Details of equity share capital
	Paid-up equity share capital	102400000	102400000
	Face value of equity share capital	1	1
27	Details of debt securities
22	Reserves excluding revaluation reserve		8980000000
23	Earnings per share
i	Earnings per equity share for continuing operations
	Basic earnings (loss) per share from continuing operations	3.66	8.03
	Diluted earnings (loss) per share from continuing operations	3.66	8.03
ii	Earnings per equity share for discontinued operations
	Basic earnings (loss) per share from discontinued operations	0	0
	Diluted earnings (loss) per share from discontinued operations	0	0
ii	Earnings per equity share
	Basic earnings (loss) per share from continuing and discontinued operations	3.66	8.03
	Diluted earnings (loss) per share from continuing and discontinued operations	3.66	8.03
24	Debt equity ratio
25	Debt service coverage ratio
26	Interest service coverage ratio
27	Disclosure of notes on financial results		Notes: n1. The Audit Committee has reviewed, and the Board of Directors has approved the above results in their respective meetings held on 15 May 2025 and 16 May 2025. n n2. In accordance with Ind AS 108, Operating Segments, the Group has identified manufacture and sale of organic chemicals as the only reportable segment. n n3. The standalone and consolidated financial results have been prepared in accordance with recognition and measurement principles laid down in the Indian Accounting Standard, prescribed under Section 133 of the Companies Act 2013, the Act, and other accounting principles generally accepted in India and is in compliance with the presentation and disclosure requirements of the regulation 33 of the SEBI (Listing obligation and disclosure requirements) Regulations, 2015 as amended. n n4. With respect to standalone and consolidated financial results, the figures for the quarters ended 31 March 2025 and 31 March 2024 represent the difference between the audited figures for the full financial years and the unaudited figures for the nine months ended 31 December 2024 and 31 December 2023, respectively.

Remarks
Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio

Statement of Asset and Liabilities
Particulars		Year ended (dd-mm-yyyy)
Date of start of reporting period		01-Apr-2024
Date of end of reporting period		31-Mar-2025
Whether results are audited or unaudited		Audited
Nature of report standalone or consolidated		Standalone
	Assets
1	Non-current assets
	Property, plant and equipment	3847800000
	Capital work-in-progress	57800000
	Investment property
	Goodwill	0
	Other intangible assets	1100000
	Intangible assets under development
	Biological assets other than bearer plants
	Investments accounted for using equity method
	Non-current financial assets
	Non-current investments	11509400000
	Trade receivables, non-current
	Loans, non-current	0
	Other non-current financial assets	36200000
	Total non-current financial assets	11545600000
	Deferred tax assets (net)
	Other non-current assets	62800000
	Total non-current assets	15515100000
2	Current assets
	Inventories	1632300000
	Current financial asset
	Current investments	0
	Trade receivables, current	2342100000
	Cash and cash equivalents	637600000
	Bank balance other than cash and cash equivalents	14600000
	Loans, current	548600000
	Other current financial assets	456100000
	Total current financial assets	3999000000
	Current tax assets (net)
	Other current assets	267300000
	Total current assets	5898600000
3	Non-current assets classified as held for sale
4	Regulatory deferral account debit balances and related deferred tax Assets
	Total assets	21413700000
	Equity and liabilities
1	Equity
	Equity attributable to owners of parent
	Equity share capital	102400000
	Other equity	10964200000
	Total equity attributable to owners of parent	11066600000
	Non controlling interest
	Total equity	11066600000
2	Liabilities
	Non-current liabilities
	Non-current financial liabilities
	Borrowings, non-current	4270100000
	Trade payables, non-current
	(A) Total outstanding dues of micro enterprises and small enterprises
	(B) Total outstanding dues of creditors other than micro enterprises and small enterprises
	Total Trade payable
	Other non-current financial liabilities	27900000
	Total non-current financial liabilities	4298000000
	Provisions, non-current	125000000
	Deferred tax liabilities (net)	600400000
	Deferred government grants, Non-current
	Other non-current liabilities
	Total non-current liabilities	5023400000
	Current liabilities
	Current financial liabilities
	Borrowings, current	921400000
	Trade payables, current
	(A) Total outstanding dues of micro enterprises and small enterprises	78000000
	(B) Total outstanding dues of creditors other than micro enterprises and small enterprises	3960800000
	Total Trade payable	4038800000
	Other current financial liabilities	256600000
	Total current financial liabilities	5216800000
	Other current liabilities	58800000
	Provisions, current	48100000
	Current tax liabilities (Net)
	Deferred government grants, Current
	Total current liabilities	5323700000
3	Liabilities directly associated with assets in disposal group classified as held for sale
4	Regulatory deferral account credit balances and related deferred tax liability
	Total liabilities	10347100000
	Total equity and liabilites	21413700000
	Disclosure of notes on assets and liabilities

Format for Reporting Segmenet wise Revenue, Results and Capital Employed along with the company results
Particulars		3 months/ 6 month ended (dd-mm-yyyy)	Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period		01-Jan-2025	01-Apr-2024
Date of end of reporting period		31-Mar-2025	31-Mar-2025
Whether accounts are audited or unaudited		Audited	Audited
Nature of report standalone or consolidated		Standalone	Standalone
1	Segment Revenue (Income)
	(net sale/income from each segment should be disclosed)
	Total Segment Revenue
	Less: Inter segment revenue
	Revenue from operations
2	Segment Result
	Profit (+) / Loss (-) before tax and interest from each segment
	Total Profit before tax
	i. Finance cost
	ii. Other Unallocable Expenditure net off Unallocable income
	Profit before tax
3	(Segment Asset - Segment Liabilities)
	Segment Asset
	Total Segment Asset
	Un-allocable Assets	null	null
	Net Segment Asset	null	null
4	Segment Liabilities
	Segment Liabilities
	Total Segment Liabilities
	Un-allocable Liabilities	null	null
	Net Segment Liabilities	null	null
	Disclosure of notes on segments

Other Comprehensive Income
Particulars		3 months/ 6 months ended (dd-mm-yyyy)	Year to date figures for current period ended (dd-mm-yyyy)
A	Date of start of reporting period	01-Jan-2025	01-Apr-2024
B	Date of end of reporting period	31-Mar-2025	31-Mar-2025
C	Whether results are audited or unaudited	Audited	Audited
D	Nature of report standalone or consolidated	Standalone	Standalone
	Other comprehensive income [Abstract]
1	Amount of items that will not be reclassified to profit and loss
1	Re-measurement of defined benefit plans	4300000	800000
2	Equity instruments through other Comprehensive income, net	-256500000	602000000
	Total Amount of items that will not be reclassified to profit and loss	-252200000	602800000
2	Income tax relating to items that will not be reclassified to profit or loss	-36700000	95400000
3	Amount of items that will be reclassified to profit and loss
	Total Amount of items that will be reclassified to profit and loss
4	Income tax relating to items that will be reclassified to profit or loss	0	0
5	Total Other comprehensive income	-215500000	507400000

Cash flow statement, indirect
Particulars				Year ended (dd-mm-yyyy)
A	Date of start of reporting period			2024-04-01
B	Date of end of reporting period			2025-03-31
C	Whether results are audited or unaudited			Audited
D	Nature of report standalone or consolidated			Standalone
Part I	Blue color marked fields are non-mandatory.
	Statement of cash flows
	Cash flows from used in operating activities
	Profit before tax			1045100000
	Adjustments for reconcile profit (loss)
	Adjustments for finance costs			444800000
	Adjustments for decrease (increase) in inventories			534300000
	Adjustments for decrease (increase) in trade receivables, current			-693400000
	Adjustments for decrease (increase) in trade receivables, non-current			0
	Adjustments for decrease (increase) in other current assets			606300000
	Adjustments for decrease (increase) in other non-current assets			10900000
	Adjustments for other financial assets, non-current			6900000
	Adjustments for other financial assets, current			-246600000
	Adjustments for other bank balances			0
	Adjustments for increase (decrease) in trade payables, current			-534000000
	Adjustments for increase (decrease) in trade payables, non-current			0
	Adjustments for increase (decrease) in other current liabilities			-30400000
	Adjustments for increase (decrease) in other non-current liabilities			0
	Adjustments for depreciation and amortisation expense			339000000
	Adjustments for impairment loss reversal of impairment loss recognised in profit or loss			0
	Adjustments for provisions, current			0
	Adjustments for provisions, non-current			0
	Adjustments for other financial liabilities, current			30500000
	Adjustments for other financial liabilities, non-current			0
	Adjustments for unrealised foreign exchange losses gains			0
	Adjustments for dividend income			22200000
	Adjustments for interest income			39400000
	Adjustments for share-based payments			0
	Adjustments for fair value losses (gains)			0
	Adjustments for undistributed profits of associates			0
	Other adjustments for which cash effects are investing or financing cash flow			0
	Other adjustments to reconcile profit (loss)			0
	Other adjustments for non-cash items			-186100000
	Share of profit and loss from partnership firm or association of persons or limited liability partnerships			0
	Total adjustments for reconcile profit (loss)			220600000
	Net cash flows from (used in) operations			1265700000
	Dividends received			0
	Interest paid			0
	Interest received			0
	Income taxes paid (refund)			217700000
	Other inflows (outflows) of cash			0
	Net cash flows from (used in) operating activities			1048000000
	Cash flows from used in investing activities
	Cash flows from losing control of subsidiaries or other businesses			0
	Cash flows used in obtaining control of subsidiaries or other businesses			0
	Other cash receipts from sales of equity or debt instruments of other entities			0
	Other cash payments to acquire equity or debt instruments of other entities			4605300000
	Other cash receipts from sales of interests in joint ventures			0
	Other cash payments to acquire interests in joint ventures			0
	Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships			0
	Cash payment for investment in partnership firm or association of persons or limited liability partnerships			0
	Proceeds from sales of property, plant and equipment			-126000000
	Purchase of property, plant and equipment			-22900000
	Proceeds from sales of investment property			0
	Purchase of investment property			0
	Proceeds from sales of intangible assets			0
	Purchase of intangible assets			0
	Proceeds from sales of intangible assets under development			0
	Purchase of intangible assets under development			0
	Proceeds from sales of goodwill			0
	Purchase of goodwill			0
	Proceeds from biological assets other than bearer plants			0
	Purchase of biological assets other than bearer plants			0
	Proceeds from government grants			0
	Proceeds from sales of other long-term assets			0
	Purchase of other long-term assets			0
	Cash advances and loans made to other parties			0
	Cash receipts from repayment of advances and loans made to other parties			0
	Cash payments for future contracts, forward contracts, option contracts and swap contracts			0
	Cash receipts from future contracts, forward contracts, option contracts and swap contracts			0
	Dividends received			21000000
	Interest received			30800000
	Income taxes paid (refund)			0
	Other inflows (outflows) of cash			-197600000
	Net cash flows from (used in) investing activities	-4854200000
	Cash flows from used in financing activities
	Proceeds from changes in ownership interests in subsidiaries			0
	Payments from changes in ownership interests in subsidiaries			0
	Proceeds from issuing shares			0
	Proceeds from issuing other equity instruments			0
	Payments to acquire or redeem entity's shares			0
	Payments of other equity instruments			0
	Proceeds from exercise of stock options			0
	Proceeds from issuing debentures notes bonds etc			0
	Proceeds from borrowings			8998400000
	Repayments of borrowings			5617200000
	Payments of lease liabilities			36800000
	Dividends paid			102400000
	Interest paid			430000000
	Income taxes paid (refund)			0
	Other inflows (outflows) of cash			0
	Net cash flows from (used in) financing activities			2812000000
	Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes			-994200000
	Effect of exchange rate changes on cash and cash equivalents
	Effect of exchange rate changes on cash and cash equivalents			34300000
	Net increase (decrease) in cash and cash equivalents			-959900000
	Cash and cash equivalents cash flow statement at beginning of period			1597500000
	Cash and cash equivalents cash flow statement at end of period			637600000